Use of Advanced Echocardiographic Modalities to Discriminate Preclinical Hypertrophic Cardiomyopathy Mutation

Ada K C Lo1,2, Thomas Mew3, Christina Mew2

  • 1Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia (A.K.C.L., A.N., J.M., S.P., J.J.A.).

Insights

Advanced echocardiography can identify hypertrophic cardiomyopathy (HCM) mutation carriers before heart muscle thickening. Color M-mode velocity propagation and apical rotation effectively distinguish individuals with HCM gene mutations from those without.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Identifying hypertrophic cardiomyopathy (HCM) risk in families is challenging.
  • Standard echocardiography fails to differentiate HCM gene carriers from non-carriers.
  • Advanced echocardiographic techniques may offer improved discrimination.

Purpose of the Study:

  • To assess if advanced echocardiographic modalities can distinguish genotype-positive, phenotype-negative (G+P-) from genotype-negative, phenotype-negative (G-P-) individuals.
  • To identify early markers of HCM in at-risk family members.

Main Methods:

  • Comprehensive echocardiography, including speckle tracking and color M-mode, was performed on 199 participants (≥16 years) from HCM families.
  • Participants included G+P- (n=58), G-P- (n=39), and overt HCM patients (n=102).
  • Primary analysis compared G+P- and G-P- individuals; secondary analysis focused on younger subjects (≤40 years).

Main Results:

  • G+P- individuals showed a higher septal/posterior wall thickness ratio compared to G-P- individuals.
  • Significantly lower color M-mode velocity propagation and higher global longitudinal strain/circumferential strain/apical rotation were observed in G+P- individuals.
  • Multivariable analysis identified color M-mode velocity propagation and peak apical rotation as independent predictors, achieving 82.6% sensitivity and 72.2% specificity in discrimination.

Conclusions:

  • Color M-mode velocity propagation and apical rotation demonstrate potential as early disease markers for HCM in mutation carriers.
  • These advanced echocardiographic measures can effectively identify carriers before the development of hypertrophy.
  • Further longitudinal studies with larger cohorts are needed for validation.
Abstract